Valuation: Novartis AG

Market Cap 284B 248B 229B 211B 398B 27,317B 407B 2,734B 1,075B 13,356B 1,066B 1,042B 46,118B P/E 2026 *
21.7x
P/E 2027 * 18.3x
Enterprise Value 316B 276B 255B 235B 443B 30,397B 453B 3,043B 1,197B 14,862B 1,186B 1,160B 51,318B EV / Sales 2026 *
5.55x
EV / Sales 2027 * 5.18x
Free-Float
91.66%
Yield 2026 *
2.84%
Yield 2027 * 2.93%
1 day+1.41%
1 week+0.58%
Current month-1.25%
1 month+5.90%
3 months+5.20%
6 months+8.13%
Current year+14.05%
1 week 121.06
Extreme 121.06
125.36
1 month 117.96
Extreme 117.96
128.92
Current year 107.68
Extreme 107.68
131
1 year 91.2
Extreme 91.2
131
3 years 81.1
Extreme 81.1
131
5 years 72.84
Extreme 72.84
131
10 years 65.09
Extreme 65.09
131
Manager TitleAgeSince
Chief Executive Officer 50 01/02/2018
Director of Finance/CFO - 16/03/2026
Chief Tech/Sci/R&D Officer 64 16/05/2022
Director TitleAgeSince
Director/Board Member 67 01/01/2015
Director/Board Member 69 01/01/2016
Director/Board Member 61 01/01/2016
Date Insider Type Main position Quantity % Market Cap.
5/18/26 A Sell -5,200 0.0003%
5/4/26 A Sell 6,800 0.0003%
2/17/26 A Sell 30,743 0.0015%
Change 5-day change 1-year change 3-year change Capi.($)
+1.41%+0.58%+35.44%+40.67% 284B
+0.85%-0.80%+52.79%+161.33% 1,051B
+1.23%-1.53%+54.58%+59.08% 609B
+0.04%+2.58%+34.47%+86.33% 450B
+0.78%-0.71%+29.28%+24.10% 330B
-0.27%-1.87%+22.34%+22.51% 263B
-1.76%+2.37%-20.43%-38.00% 223B
-1.42%+0.80%+24.27%+57.50% 198B
-1.48%+3.43%+24.08%+71.67% 167B
-0.36%+3.64%+2.37%-30.88% 143B
Average -0.10%+0.85%+25.92%+45.43% 371.78B
Weighted average by Cap. +0.34%+0.16%+36.16%+75.39%

Financials

2026 *2027 *
Net sales 56.91B 49.8B 46B 42.34B 79.77B 5,478B 81.64B 548B 216B 2,678B 214B 209B 9,249B 60.31B 52.78B 48.75B 44.87B 84.54B 5,806B 86.53B 581B 229B 2,839B 226B 222B 9,802B
Net income 14.08B 12.32B 11.38B 10.47B 19.74B 1,355B 20.2B 136B 53.36B 663B 52.87B 51.71B 2,288B 15.64B 13.69B 12.64B 11.64B 21.93B 1,506B 22.44B 151B 59.29B 736B 58.74B 57.45B 2,542B
Net Debt 32B 28B 25.86B 23.81B 44.85B 3,080B 45.91B 308B 121B 1,506B 120B 118B 5,201B 28.48B 24.92B 23.02B 21.19B 39.92B 2,742B 40.86B 274B 108B 1,340B 107B 105B 4,629B
Logo Novartis AG
Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales break down by therapeutic area as follows: - oncology (30.9%); - immunology (18.9%); - cardiovascular, renal and metabolic diseases (16.4%); - neuroscience (11%). The remaining net sales (22.8%) are from contract manufacturing of pharmaceutical products. At the end of 2025, Novartis AG had over 31 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (2.6%), Europe (28.1%), the United States (42.8%), Asia/Africa/Australasia (19.8%), Canada and Latin America (6.7%).
Employees
75,267
Date Price Change Volume
17/07/26 CHF 125.00 +1.41% 2,979,184
16/07/26 CHF 123.26 +1.03% 2,306,603
15/07/26 CHF 122.00 -0.34% 1,730,393
14/07/26 CHF 122.42 -1.73% 2,431,098
13/07/26 CHF 124.58 +0.24% 2,143,959
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
22
Last Close Price
155.01USD
Average target price
152.72USD
Spread / Average Target
-1.48%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. NOVN Stock